Hydrosone Cream
Natural health product licensed in Canada
- Licence holder
- Teva Canada Limited
- NPN or DIN-HM
- 00564281
- Status
- Active licence
- Licence date
- 16 November 2007
- Revision date
- 12 April 2022
- Form
- Crème
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
myritol 318, Alcool cétostéarylique, (p)-hydroxybenzoate de propyle, Glycérine, emulgin B2, Eau purifiée, Parahydroxybenzoate de méthyle, Emulgin B1
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years | Not specified | maximum: 4 Tous les jours |
| Adultes | Not specified | Not specified | maximum: 4 Tous les jours |
Uses authorised in Canada
Topical corticosteriod, for the temporary relief of minor skin irritations, itching and redness
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 00564281
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging